CA3118765C - Composés pour le traitement d’une infection à arénavirus - Google Patents

Composés pour le traitement d’une infection à arénavirus

Info

Publication number
CA3118765C
CA3118765C CA3118765A CA3118765A CA3118765C CA 3118765 C CA3118765 C CA 3118765C CA 3118765 A CA3118765 A CA 3118765A CA 3118765 A CA3118765 A CA 3118765A CA 3118765 C CA3118765 C CA 3118765C
Authority
CA
Canada
Prior art keywords
compound
independently selected
pct
alkyl
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3118765A
Other languages
English (en)
Other versions
CA3118765A1 (fr
Inventor
Eric Brown
Vidyasagar Reddy Gantla
Nadezda Sokolova
Michael Bruno Plewe
Gregory Henkel
Kenneth McCormack
Original Assignee
Arisan Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arisan Therapeutics Inc filed Critical Arisan Therapeutics Inc
Priority claimed from PCT/US2019/064223 external-priority patent/WO2020117794A1/fr
Publication of CA3118765A1 publication Critical patent/CA3118765A1/fr
Application granted granted Critical
Publication of CA3118765C publication Critical patent/CA3118765C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

Il est décrit des composés tels que le composé A qui sont utiles dans le traitement d’infections à arénavirus et d’infections virales médiées par des glycoprotéines d’arénavirus.
CA3118765A 2018-12-06 2019-12-03 Composés pour le traitement d’une infection à arénavirus Active CA3118765C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862776390P 2018-12-06 2018-12-06
US62/776,390 2018-12-06
PCT/US2019/064223 WO2020117794A1 (fr) 2018-12-06 2019-12-03 Composés pour le traitement d'une infection à arénavirus

Publications (2)

Publication Number Publication Date
CA3118765A1 CA3118765A1 (fr) 2020-06-11
CA3118765C true CA3118765C (fr) 2025-07-08

Family

ID=

Similar Documents

Publication Publication Date Title
US11352328B2 (en) Heterocyclic compounds for the treatment of arenavirus
AU2018331172B2 (en) Influenza virus replication inhibitor and use thereof
US11548893B2 (en) Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection
CN112940010B (zh) 经取代的多环性吡啶酮衍生物及其前药
Pan et al. Development of benzimidazole derivatives to inhibit HIV-1 replication through protecting APOBEC3G protein
US12240857B2 (en) Adamantane derivatives for the treatment of filovirus infection
CN109415367A (zh) 用于治疗和预防乙型肝炎病毒感染的新的二氢吡咯并嘧啶类化合物
WO2016071293A2 (fr) Composé pharmaceutique
AU2019393784B2 (en) Compounds for the treatment of arenavirus infection
CA3235441A1 (fr) Composes et methodes de traitement des coronavirus
CN112521386B (zh) 具有抗病毒作用的多环吡啶酮化合物及其药物组合和用途
JP6859358B2 (ja) テトラヒドロインダゾール及びその医学的使用
WO2021205290A1 (fr) Composés et procédé de traitement de la covid-19
US20210244721A1 (en) Small molecule enterovirus inhibitors and uses thereof
US12419865B2 (en) Compounds for the treatment of arenavirus infection
CA3118765C (fr) Composés pour le traitement d’une infection à arénavirus
JP6562926B2 (ja) １−（３−アミノプロピル）置換環状アミン系化合物、その製造方法、薬物組成物および使用
OA20266A (fr)
WO2021262426A9 (fr) Amides et thioamides d'adamantane pour le traitement d'une infection par le virus ebola
EA044865B1 (ru) Соединения для лечения аренавирусной инфекции
Gaisina et al. Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of Henipaviruses
TW202317093A (zh) 具有hiv複製抑制作用之縮合雜環衍生物
NZ791086A (en) Substituted polycyclic pyridone derivative and pharmaceutical composition containing prodrug thereof
HK1116090A (en) Thiazole compounds and methods of use